Meridian Bioscience Inc.

-0.14 (-0.44%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.39B
Current PE32.07
Forward PE 23.95
2yr Forward PE 36.33
See more stats
Estimates Current Quarter
Revenue$67.45 Million
Adjusted EPS$0.15
See more estimates
10-Day MA$31.97
50-Day MA$32.38
200-Day MA$27.09
See more pivots

Meridian Bioscience Inc. Stock, NASDAQ:VIVO

3471 River Hills Drive, Cincinnati, Ohio 45244
United States of America
Phone: +1.513.271.3700
Number of Employees: 760


Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. Its platforms include molecular, immunoassay, urea breath, and blood chemistry. It operates through the Diagnostics and Life Science segments. The Diagnostics segment consists of manufacturing operations for infectious disease and blood chemistry products and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment distributes bulk antigens, antibodies, polymerase chain reaction/ quantitative PCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.